Global Malaria Rapid Diagnostic Tests (RDTS) Market By Product Type (Detect Only One Species and Detect Multiple Species), By End Users (Hospital, Clinic and Others), By Region and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2022–2031

Market.us announces the publication of its most recently generated research report titled, “Global Malaria Rapid Diagnostic Tests (RDTS) Market by Product Type (Detect only one Species and Detect Multiple Species), By End Users (Hospital, Clinic and Others), and by Region – Global Forecast to 2031.”, Which offers a holistic view of global malaria rapid diagnostic tests (RDTS) market through systematic segmentation that covers every aspect of the target market.

The global malaria rapid diagnostic tests (RDTS) market is projected to be US$ 266 Mn in 2018 to reach US$ 415.7 Mn by 2028 at a CAGR of 4.6%.

Malaria is predominant in tropical countries because temperature conditions in these regions are suitable for the growth of mosquitos. Malaria Rapid Diagnostic Tests (RDTS) are used to detect the presence of malaria antigen in the blood. RDTs are very easy to use, and no skilled professionals are required to conduct this test. One can conduct this test on his own from where they are. The use of Malaria Rapid Diagnostic Tests (RDTS) is becoming popular especially in rural areas because of its user-friendliness, and the lack of skilled technicians as well as microscopes in rural areas. Also, the result time of Malaria Rapid Diagnostic Tests (RDTS) is just about 15 to 20 minutes which is quite impressive taking into account its price and availability in the market. No infrastructure is required to carry out rapid diagnostic tests hence reduction in costs which facilitates the market growth. Malaria Rapid Diagnostic Tests (RDTS) is considered an alternative to conventional tests conducted in clinics or pathology labs. Malaria RDTs are comparatively inexpensive and still, their results are excellent. Due to the competitive environment, the prices are declining which is expected to boost the malaria rapid diagnostic tests market further. The Malaria RDT evaluation program initiated by WHO and Foundation for Innovative New Diagnostics (FIND) to make pre-purchase performance evaluation and pre-distribution quality control makes the process more transparent. Healthcare professionals are increasingly giving importance to WHO compliant RDT products which in turn increases the quality of RDTs offered by manufacturers which are predicted to assist in the market progress.

These rapid diagnostic tests are particularly useful in rural areas where access to hospitals, labs, trained technicians as well as equipment such as microscopes to diagnose Malaria, is somewhat limited which is predicted to drive the RDTs market forward.

Global Malaria Rapid Diagnostic Tests (RDTS) Market Revenue (US$ Mn), 2018–2028 

However, the Slow process of prequalification by the World Health Organization of RDTs could affect the growth of the Malaria Rapid Diagnostic Tests (RDTS) Market. Nonetheless, the Global Fund as well as Government initiatives such as the United States President’s Malaria Initiative (PMI), etc. are investing in preventing and curing Malaria which is expected to widen the rapid diagnostic tests market scope.

The global Malaria Rapid Diagnostic Tests (RDTS) market is segmented on the basis of product type, end-user and region. On the basis of product type, the market is segmented into Detect only one Species and Detect Multiple Species. The Detect, only one Species segment, accounts for the majority share and is expected to register the highest growth over the forecast period, followed by Detect Multiple Species segment. On the basis of end-user, the market is segmented into Hospitals, Clinics and Others. The hospital segment accounts for a majority share in the global Malaria Rapid Diagnostic Tests (RDTS) market.

Global Malaria Rapid Diagnostic Tests (RDTS) Market by End User, 2018

On the basis of region, the market is segmented into Africa, APAC, and ROW. Africa accounts for the majority share in the global Malaria Rapid Diagnostic Tests (RDTS) market, as rapid diagnostic tests are particularly useful in rural areas where access to hospitals, labs, trained technicians as well as equipment such as microscopes to diagnose Malaria, is somewhat limited which is predicted to drive the RDTs market forward. APAC is expected to register the highest growth rate over the forecast period.

The research report on the global Malaria Rapid Diagnostic Tests (RDTS) market includes profiles of some of the major companies such as Abbott Laboratories (Alere Inc.)., Access Bio, Inc., Bio-Rad Laboratories, Inc., Access Bio Inc., Linde Plc and BioMérieux, Inc.

Key Market Segments:

Type

• Detect only one Species
• Detect Multiple Species

Application

• Hospital
• Clinic and Others

Key Market Players included in the report:

• Abbott Laboratories (Alere Inc.)
• Access Bio Inc.
• Bio-Rad Laboratories Inc.
• Access Bio Inc.
• Linde Plc and BioMérieux Inc

For the Malaria Rapid Diagnostic Tests (RDTS) Market research study, the following years have been considered to estimate the market size: